Overview
- Roughly 99% of investors approved varying the use of IPO proceeds, lifting the organic growth allocation to INR 1,200 crore and trimming R&D to INR 1,505 crore.
- The company added a new INR 395 crore bucket for repayment or prepayment of debt and signaled plans to refinance corporate borrowings with board approval to issue fresh NCDs.
- Unutilised balances now stand at INR 1,049 crore for R&D, INR 901 crore for organic growth, INR 395 crore for debt service and INR 248 crore for general corporate purposes.
- Shares fell 3.38% to INR 47.18, and both NSE and BSE placed the stock under the short-term Additional Surveillance Measure framework following sharp price swings.
- Management said IPO funds have already supported cell-plant expansion, and recent announcements include a ferrite motor, 4680 Bharat Cell integration, new two-wheeler models and MoveOS 6.